Showing 18,141 - 18,160 results of 74,121 for search '(( 5 ((we decrease) OR (mean decrease)) ) OR ( 50 ((nn decrease) OR (a decrease)) ))', query time: 0.87s Refine Results
  1. 18141

    Effects of Tra2β over-expression and silence on RGS4 expression in SH-SY5Y cultured cells and rat LC. by Shu-Jing Li (447460)

    Published 2013
    “…*<i>p</i><0.05, **<i>p</i><0.01, ***<i>p</i><0.001 compared to 0 µg group, using one-way ANOVA. (F) Tra2β RNAi decreased relative protein level (%GAPDH) of RGS4 (0.55±0.03) in SH-SY5Y cells. …”
  2. 18142

    Table_5_The Effect of Dexmedetomidine on Emergence Agitation or Delirium in Children After Anesthesia—A Systematic Review and Meta-Analysis of Clinical Studies.DOC by Yuquan Rao (9118304)

    Published 2020
    “…<p>Background: We conducted this systematic review and meta-analysis to investigate the clinical effect of dexmedetomidine in preventing pediatric emergence agitation (EA) or delirium (ED) following anesthesia compared with placebo or other sedatives.…”
  3. 18143

    Table_5_Which Factors Affect the Occurrence of Off-Target Effects Caused by the Use of CRISPR/Cas: A Systematic Review in Plants.XLSX by Dominik Modrzejewski (5639621)

    Published 2020
    “…All studies included in the systematic review were synthesized in a narrative report, but studies rated as high and medium/high validity were reported separately from studies rated as low and medium/low or unclear validity. In addition, we ran a binary logistic regression analysis to verify five factors that may affect the occurrence of off-target effects: (1) Number of mismatches (2) Position of mismatches (3) GC-content of the targeting sequence (4) Altered nuclease variants (5) Delivery methods. …”
  4. 18144
  5. 18145
  6. 18146
  7. 18147
  8. 18148
  9. 18149
  10. 18150
  11. 18151
  12. 18152
  13. 18153
  14. 18154
  15. 18155
  16. 18156
  17. 18157
  18. 18158
  19. 18159

    Data_Sheet_1_Clinical Parameters in Osteoporosis Patients Supplemented With PMA-Zeolite at the End of 5-Year Double-Blinded Clinical Trial.docx by Sandra Kraljević Pavelić (3845662)

    Published 2022
    “…The rationale of the presented study was accordingly, to expand our preclinical animal study on human patients with osteoporosis, based on positive effects on bones observed in animals with osteopenia treated with PMA-zeolite. We specifically monitored effects of PMA-zeolite on the bone quality parameters, fracture risk and quality of life in a cohort of initially recruited 100 osteoporosis patients during a follow-up period of 5 years within a randomized, placebo-controlled and double blinded clinical study (TOP study). …”
  20. 18160